Earlier this year, the Susan G. Komen Foundation made headlines around the world after their politically-charged decision to cut funding for breast cancer screening at Planned Parenthood caused outrage and negatively impacted donations. Despite reversing the decision and apologizing, many people in the health care and fund raising community feel that the aftermath of the controversy still dogs the foundation. Indeed, Advertising Age literally referred to it as a PR crisis. If all of this sounds more like spin for a brand rather than a charity working towards the cure of a devastating illness, it’s not far from the truth. Susan G. Komen For the Cure, Avon Walk For Breast Cancer and the Revlon Run/Walk For Women represent a triumvirate hegemony in the “pink ribbon” fundraising domain. Over time, their initial breast cancer awareness movement (and everything the pink ribbon stood for symbolically) has moved from activism to pure consumerism. The new documentary Pink Ribbons, Inc. deftly and devastatingly examines the rise of corporate culture in breast cancer fundraising. Who is really profiting from these pink ribbon campaigns, brands or people with the disease? How has the positional messaging of these “pink ribbon” events impacted the women who are actually facing the illness? And finally, has motivation for profit driven the very same companies whose products cause cancer to benefit from the disease? ScriptPhD.com’s Selling Science Smartly advertising series continues with a review of Pink Ribbons, Inc..
Continue reading Selling Science Smartly: ‘Pink Ribbons, Inc.’ and Breast Cancer as a Profit Industry
